• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, December 20, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home Headlines

More than 100,000 switches

Bioengineer.org by Bioengineer.org
January 29, 2018
in Headlines, Health, Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Graphic: Lutz Grein

Information for building cells is stored in our genetic material, otherwise known as DNA. It is here that you find all the blueprints for the more than 20,000 different proteins in the human body. Each and every cell requires several thousand different proteins in order to function. If you were to roll every single protein blueprint into one, the information they contain would fit on less than two percent of all DNA. What are the remaining 98 percent of the genomes needed for? The switches that control gene activity are located here. For the first time, a research team led by Dr. Ralf Gilsbach and Prof. Dr. Lutz Hein from the Institute of Experimental and Clinical Pharmacology and Toxicology at the University of Freiburg have mapped out the gene regulators in the DNA of human cardiac muscle cells. The findings have been published in the journal Nature Communications.

In order to locate all gene switches, the Freiburg research team used modern sequencing methods to examine the entire genome – DNA, epigenetic markers and RNA – during the development, maturation and disease of human cardiac muscle cells. By analyzing more than a trillion sequencing letters, the team found over 100,000 gene switches. The multitude of data now yields a complete atlas of gene regulators in the life of a cardiac muscle cell. During development and growth, DNA methylation and histone markers control which genes are turned on or off. The atlas also provides insight into mechanisms that are misdirected in heart disease. Some regulatory elements are altered in cardiac arrhythmias at the DNA level, for example. In contrast, histones take control in chronic heart failure. In the future, the Freiburg researchers want to identify the most important switches in this atlas in order to treat heart disease.

###

Original publication:

Ralf Gilsbach, Martin Schwaderer, Sebastian Preissl, Björn A. Grüning, David Kranzhöfer, Pedro Schneider, Thomas G. Nührenberg, Sonia Mulero-Navarro, Dieter Weichenhan, Christian Braun, Martina Dreßen, Adam R. Jacobs, Harald Lahm, Torsten Doenst, Rolf Backofen, Markus Krane, Bruce D. Gelb, Lutz Hein (2018): Distinct epigenetic programs regulate cardiac myocyte development and disease in the human heart in vivo. In: Nature Communications. http://dx.doi.org/10.1038/s41467-017-02762-z

Contact:

Institute of Experimental and Clinical Pharmacology and Toxicology
University of Freiburg
Fax: 49761-203-5314

Media Contact

Dr. Lutz Hein
[email protected]
761-203-5314

Startseite

Original Source

https://www.pr.uni-freiburg.de/pm-en/press-releases-2018/more-than-100-000-switches?set_language=en

Share12Tweet8Share2ShareShareShare2

Related Posts

Caregiver Struggles and Solutions for Dementia in Africa

December 20, 2025

Neonatal Sepsis Variations in Preterm Infants Studied

December 20, 2025

Synergistic Antidiabetic Benefits of Voglibose and Ubiquinone

December 20, 2025

New Therapy Combines Flt-1 and Paclitaxel Against Breast Cancer

December 20, 2025
Please login to join discussion

POPULAR NEWS

  • Nurses’ Views on Online Learning: Effects on Performance

    Nurses’ Views on Online Learning: Effects on Performance

    70 shares
    Share 28 Tweet 18
  • NSF funds machine-learning research at UNO and UNL to study energy requirements of walking in older adults

    71 shares
    Share 28 Tweet 18
  • Unraveling Levofloxacin’s Impact on Brain Function

    53 shares
    Share 21 Tweet 13
  • Exploring Audiology Accessibility in Johannesburg, South Africa

    51 shares
    Share 20 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Caregiver Struggles and Solutions for Dementia in Africa

Neonatal Sepsis Variations in Preterm Infants Studied

Synergistic Antidiabetic Benefits of Voglibose and Ubiquinone

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 70 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.